Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Therapy and Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Cancer Detection
1.2.3 Cancer Treatment
1.3 Market by Application
1.3.1 Global Cancer Therapy and Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Lung Cancer
1.3.3 Rectal Cancer
1.3.4 Breast Cancer
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Therapy and Testing Market Perspective (2018-2033)
2.2 Global Cancer Therapy and Testing Growth Trends by Region
2.2.1 Cancer Therapy and Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Cancer Therapy and Testing Historic Market Size by Region (2018-2023)
2.2.3 Cancer Therapy and Testing Forecasted Market Size by Region (2024-2033)
2.3 Cancer Therapy and Testing Market Dynamics
2.3.1 Cancer Therapy and Testing Industry Trends
2.3.2 Cancer Therapy and Testing Market Drivers
2.3.3 Cancer Therapy and Testing Market Challenges
2.3.4 Cancer Therapy and Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Cancer Therapy and Testing by Players
3.1.1 Global Cancer Therapy and Testing Revenue by Players (2018-2023)
3.1.2 Global Cancer Therapy and Testing Revenue Market Share by Players (2018-2023)
3.2 Global Cancer Therapy and Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Cancer Therapy and Testing, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Cancer Therapy and Testing Market Concentration Ratio
3.4.1 Global Cancer Therapy and Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Therapy and Testing Revenue in 2022
3.5 Global Key Players of Cancer Therapy and Testing Head office and Area Served
3.6 Global Key Players of Cancer Therapy and Testing, Product and Application
3.7 Global Key Players of Cancer Therapy and Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Therapy and Testing Breakdown Data by Type
4.1 Global Cancer Therapy and Testing Historic Market Size by Type (2018-2023)
4.2 Global Cancer Therapy and Testing Forecasted Market Size by Type (2024-2033)
5 Cancer Therapy and Testing Breakdown Data by Application
5.1 Global Cancer Therapy and Testing Historic Market Size by Application (2018-2023)
5.2 Global Cancer Therapy and Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Cancer Therapy and Testing Market Size (2018-2033)
6.2 North America Cancer Therapy and Testing Market Size by Type
6.2.1 North America Cancer Therapy and Testing Market Size by Type (2018-2023)
6.2.2 North America Cancer Therapy and Testing Market Size by Type (2024-2033)
6.2.3 North America Cancer Therapy and Testing Market Share by Type (2018-2033)
6.3 North America Cancer Therapy and Testing Market Size by Application
6.3.1 North America Cancer Therapy and Testing Market Size by Application (2018-2023)
6.3.2 North America Cancer Therapy and Testing Market Size by Application (2024-2033)
6.3.3 North America Cancer Therapy and Testing Market Share by Application (2018-2033)
6.4 North America Cancer Therapy and Testing Market Size by Country
6.4.1 North America Cancer Therapy and Testing Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Cancer Therapy and Testing Market Size by Country (2018-2023)
6.4.3 North America Cancer Therapy and Testing Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Cancer Therapy and Testing Market Size (2018-2033)
7.2 Europe Cancer Therapy and Testing Market Size by Type
7.2.1 Europe Cancer Therapy and Testing Market Size by Type (2018-2023)
7.2.2 Europe Cancer Therapy and Testing Market Size by Type (2024-2033)
7.2.3 Europe Cancer Therapy and Testing Market Share by Type (2018-2033)
7.3 Europe Cancer Therapy and Testing Market Size by Application
7.3.1 Europe Cancer Therapy and Testing Market Size by Application (2018-2023)
7.3.2 Europe Cancer Therapy and Testing Market Size by Application (2024-2033)
7.3.3 Europe Cancer Therapy and Testing Market Share by Application (2018-2033)
7.4 Europe Cancer Therapy and Testing Market Size by Country
7.4.1 Europe Cancer Therapy and Testing Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Cancer Therapy and Testing Market Size by Country (2018-2023)
7.4.3 Europe Cancer Therapy and Testing Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Cancer Therapy and Testing Market Size (2018-2033)
8.2 China Cancer Therapy and Testing Market Size by Type
8.2.1 China Cancer Therapy and Testing Market Size by Type (2018-2023)
8.2.2 China Cancer Therapy and Testing Market Size by Type (2024-2033)
8.2.3 China Cancer Therapy and Testing Market Share by Type (2018-2033)
8.3 China Cancer Therapy and Testing Market Size by Application
8.3.1 China Cancer Therapy and Testing Market Size by Application (2018-2023)
8.3.2 China Cancer Therapy and Testing Market Size by Application (2024-2033)
8.3.3 China Cancer Therapy and Testing Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Cancer Therapy and Testing Market Size (2018-2033)
9.2 Asia Cancer Therapy and Testing Market Size by Type
9.2.1 Asia Cancer Therapy and Testing Market Size by Type (2018-2023)
9.2.2 Asia Cancer Therapy and Testing Market Size by Type (2024-2033)
9.2.3 Asia Cancer Therapy and Testing Market Share by Type (2018-2033)
9.3 Asia Cancer Therapy and Testing Market Size by Application
9.3.1 Asia Cancer Therapy and Testing Market Size by Application (2018-2023)
9.3.2 Asia Cancer Therapy and Testing Market Size by Application (2024-2033)
9.3.3 Asia Cancer Therapy and Testing Market Share by Application (2018-2033)
9.4 Asia Cancer Therapy and Testing Market Size by Region
9.4.1 Asia Cancer Therapy and Testing Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Cancer Therapy and Testing Market Size by Region (2018-2023)
9.4.3 Asia Cancer Therapy and Testing Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Cancer Therapy and Testing Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Cancer Therapy and Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Cancer Therapy and Testing Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Cancer Therapy and Testing Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Cancer Therapy and Testing Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Cancer Therapy and Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Cancer Therapy and Testing Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Cancer Therapy and Testing Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Cancer Therapy and Testing Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Cancer Therapy and Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Cancer Therapy and Testing Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Cancer Therapy and Testing Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Cancer Therapy and Testing Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Invitae
11.1.1 Invitae Company Details
11.1.2 Invitae Business Overview
11.1.3 Invitae Cancer Therapy and Testing Introduction
11.1.4 Invitae Revenue in Cancer Therapy and Testing Business (2018-2023)
11.1.5 Invitae Recent Developments
11.2 Foundation Medicine
11.2.1 Foundation Medicine Company Details
11.2.2 Foundation Medicine Business Overview
11.2.3 Foundation Medicine Cancer Therapy and Testing Introduction
11.2.4 Foundation Medicine Revenue in Cancer Therapy and Testing Business (2018-2023)
11.2.5 Foundation Medicine Recent Developments
11.3 Guardant Health
11.3.1 Guardant Health Company Details
11.3.2 Guardant Health Business Overview
11.3.3 Guardant Health Cancer Therapy and Testing Introduction
11.3.4 Guardant Health Revenue in Cancer Therapy and Testing Business (2018-2023)
11.3.5 Guardant Health Recent Developments
11.4 Illumina
11.4.1 Illumina Company Details
11.4.2 Illumina Business Overview
11.4.3 Illumina Cancer Therapy and Testing Introduction
11.4.4 Illumina Revenue in Cancer Therapy and Testing Business (2018-2023)
11.4.5 Illumina Recent Developments
11.5 Sysmex
11.5.1 Sysmex Company Details
11.5.2 Sysmex Business Overview
11.5.3 Sysmex Cancer Therapy and Testing Introduction
11.5.4 Sysmex Revenue in Cancer Therapy and Testing Business (2018-2023)
11.5.5 Sysmex Recent Developments
11.6 Abingdon Health
11.6.1 Abingdon Health Company Details
11.6.2 Abingdon Health Business Overview
11.6.3 Abingdon Health Cancer Therapy and Testing Introduction
11.6.4 Abingdon Health Revenue in Cancer Therapy and Testing Business (2018-2023)
11.6.5 Abingdon Health Recent Developments
11.7 Sophia
11.7.1 Sophia Company Details
11.7.2 Sophia Business Overview
11.7.3 Sophia Cancer Therapy and Testing Introduction
11.7.4 Sophia Revenue in Cancer Therapy and Testing Business (2018-2023)
11.7.5 Sophia Recent Developments
11.8 NanoEntek
11.8.1 NanoEntek Company Details
11.8.2 NanoEntek Business Overview
11.8.3 NanoEntek Cancer Therapy and Testing Introduction
11.8.4 NanoEntek Revenue in Cancer Therapy and Testing Business (2018-2023)
11.8.5 NanoEntek Recent Developments
11.9 BGI
11.9.1 BGI Company Details
11.9.2 BGI Business Overview
11.9.3 BGI Cancer Therapy and Testing Introduction
11.9.4 BGI Revenue in Cancer Therapy and Testing Business (2018-2023)
11.9.5 BGI Recent Developments
11.10 Diagnosis
11.10.1 Diagnosis Company Details
11.10.2 Diagnosis Business Overview
11.10.3 Diagnosis Cancer Therapy and Testing Introduction
11.10.4 Diagnosis Revenue in Cancer Therapy and Testing Business (2018-2023)
11.10.5 Diagnosis Recent Developments
11.11 Exact Sciences
11.11.1 Exact Sciences Company Details
11.11.2 Exact Sciences Business Overview
11.11.3 Exact Sciences Cancer Therapy and Testing Introduction
11.11.4 Exact Sciences Revenue in Cancer Therapy and Testing Business (2018-2023)
11.11.5 Exact Sciences Recent Developments
11.12 AstraZeneca
11.12.1 AstraZeneca Company Details
11.12.2 AstraZeneca Business Overview
11.12.3 AstraZeneca Cancer Therapy and Testing Introduction
11.12.4 AstraZeneca Revenue in Cancer Therapy and Testing Business (2018-2023)
11.12.5 AstraZeneca Recent Developments
11.13 Bayer AG
11.13.1 Bayer AG Company Details
11.13.2 Bayer AG Business Overview
11.13.3 Bayer AG Cancer Therapy and Testing Introduction
11.13.4 Bayer AG Revenue in Cancer Therapy and Testing Business (2018-2023)
11.13.5 Bayer AG Recent Developments
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Details
11.14.2 Johnson & Johnson Business Overview
11.14.3 Johnson & Johnson Cancer Therapy and Testing Introduction
11.14.4 Johnson & Johnson Revenue in Cancer Therapy and Testing Business (2018-2023)
11.14.5 Johnson & Johnson Recent Developments
11.15 Pfizer Inc.
11.15.1 Pfizer Inc. Company Details
11.15.2 Pfizer Inc. Business Overview
11.15.3 Pfizer Inc. Cancer Therapy and Testing Introduction
11.15.4 Pfizer Inc. Revenue in Cancer Therapy and Testing Business (2018-2023)
11.15.5 Pfizer Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cancer Therapy and Testing Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Cancer Detection
Table 3. Key Players of Cancer Treatment
Table 4. Global Cancer Therapy and Testing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Cancer Therapy and Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Cancer Therapy and Testing Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Cancer Therapy and Testing Market Share by Region (2018-2023)
Table 8. Global Cancer Therapy and Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Cancer Therapy and Testing Market Share by Region (2024-2033)
Table 10. Cancer Therapy and Testing Market Trends
Table 11. Cancer Therapy and Testing Market Drivers
Table 12. Cancer Therapy and Testing Market Challenges
Table 13. Cancer Therapy and Testing Market Restraints
Table 14. Global Cancer Therapy and Testing Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Cancer Therapy and Testing Revenue Share by Players (2018-2023)
Table 16. Global Top Cancer Therapy and Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Therapy and Testing as of 2022)
Table 17. Global Cancer Therapy and Testing Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Cancer Therapy and Testing Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Cancer Therapy and Testing, Headquarters and Area Served
Table 20. Global Key Players of Cancer Therapy and Testing, Product and Application
Table 21. Global Key Players of Cancer Therapy and Testing, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Therapy and Testing Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Cancer Therapy and Testing Revenue Market Share by Type (2018-2023)
Table 25. Global Cancer Therapy and Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Cancer Therapy and Testing Revenue Market Share by Type (2024-2033)
Table 27. Global Cancer Therapy and Testing Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Cancer Therapy and Testing Revenue Share by Application (2018-2023)
Table 29. Global Cancer Therapy and Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Cancer Therapy and Testing Revenue Share by Application (2024-2033)
Table 31. North America Cancer Therapy and Testing Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Cancer Therapy and Testing Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Cancer Therapy and Testing Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Cancer Therapy and Testing Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Cancer Therapy and Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Cancer Therapy and Testing Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Cancer Therapy and Testing Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Cancer Therapy and Testing Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Cancer Therapy and Testing Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Cancer Therapy and Testing Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Cancer Therapy and Testing Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Cancer Therapy and Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Cancer Therapy and Testing Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Cancer Therapy and Testing Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Cancer Therapy and Testing Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Cancer Therapy and Testing Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Cancer Therapy and Testing Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Cancer Therapy and Testing Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Cancer Therapy and Testing Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Cancer Therapy and Testing Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Cancer Therapy and Testing Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Cancer Therapy and Testing Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Cancer Therapy and Testing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Cancer Therapy and Testing Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Cancer Therapy and Testing Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Cancer Therapy and Testing Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Cancer Therapy and Testing Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Cancer Therapy and Testing Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Cancer Therapy and Testing Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Cancer Therapy and Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Cancer Therapy and Testing Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Cancer Therapy and Testing Market Size by Country (2024-2033) & (US$ Million)
Table 63. Invitae Company Details
Table 64. Invitae Business Overview
Table 65. Invitae Cancer Therapy and Testing Product
Table 66. Invitae Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 67. Invitae Recent Developments
Table 68. Foundation Medicine Company Details
Table 69. Foundation Medicine Business Overview
Table 70. Foundation Medicine Cancer Therapy and Testing Product
Table 71. Foundation Medicine Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 72. Foundation Medicine Recent Developments
Table 73. Guardant Health Company Details
Table 74. Guardant Health Business Overview
Table 75. Guardant Health Cancer Therapy and Testing Product
Table 76. Guardant Health Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 77. Guardant Health Recent Developments
Table 78. Illumina Company Details
Table 79. Illumina Business Overview
Table 80. Illumina Cancer Therapy and Testing Product
Table 81. Illumina Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 82. Illumina Recent Developments
Table 83. Sysmex Company Details
Table 84. Sysmex Business Overview
Table 85. Sysmex Cancer Therapy and Testing Product
Table 86. Sysmex Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 87. Sysmex Recent Developments
Table 88. Abingdon Health Company Details
Table 89. Abingdon Health Business Overview
Table 90. Abingdon Health Cancer Therapy and Testing Product
Table 91. Abingdon Health Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 92. Abingdon Health Recent Developments
Table 93. Sophia Company Details
Table 94. Sophia Business Overview
Table 95. Sophia Cancer Therapy and Testing Product
Table 96. Sophia Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 97. Sophia Recent Developments
Table 98. NanoEntek Company Details
Table 99. NanoEntek Business Overview
Table 100. NanoEntek Cancer Therapy and Testing Product
Table 101. NanoEntek Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 102. NanoEntek Recent Developments
Table 103. BGI Company Details
Table 104. BGI Business Overview
Table 105. BGI Cancer Therapy and Testing Product
Table 106. BGI Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 107. BGI Recent Developments
Table 108. Diagnosis Company Details
Table 109. Diagnosis Business Overview
Table 110. Diagnosis Cancer Therapy and Testing Product
Table 111. Diagnosis Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 112. Diagnosis Recent Developments
Table 113. Exact Sciences Company Details
Table 114. Exact Sciences Business Overview
Table 115. Exact Sciences Cancer Therapy and Testing Product
Table 116. Exact Sciences Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 117. Exact Sciences Recent Developments
Table 118. AstraZeneca Company Details
Table 119. AstraZeneca Business Overview
Table 120. AstraZeneca Cancer Therapy and Testing Product
Table 121. AstraZeneca Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 122. AstraZeneca Recent Developments
Table 123. Bayer AG Company Details
Table 124. Bayer AG Business Overview
Table 125. Bayer AG Cancer Therapy and Testing Product
Table 126. Bayer AG Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 127. Bayer AG Recent Developments
Table 128. Johnson & Johnson Company Details
Table 129. Johnson & Johnson Business Overview
Table 130. Johnson & Johnson Cancer Therapy and Testing Product
Table 131. Johnson & Johnson Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 132. Johnson & Johnson Recent Developments
Table 133. Pfizer Inc. Company Details
Table 134. Pfizer Inc. Business Overview
Table 135. Pfizer Inc. Cancer Therapy and Testing Product
Table 136. Pfizer Inc. Revenue in Cancer Therapy and Testing Business (2018-2023) & (US$ Million)
Table 137. Pfizer Inc. Recent Developments
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Therapy and Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Cancer Therapy and Testing Market Share by Type: 2022 VS 2033
Figure 3. Cancer Detection Features
Figure 4. Cancer Treatment Features
Figure 5. Global Cancer Therapy and Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Cancer Therapy and Testing Market Share by Application: 2022 VS 2033
Figure 7. Lung Cancer Case Studies
Figure 8. Rectal Cancer Case Studies
Figure 9. Breast Cancer Case Studies
Figure 10. Other Case Studies
Figure 11. Cancer Therapy and Testing Report Years Considered
Figure 12. Global Cancer Therapy and Testing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Cancer Therapy and Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Cancer Therapy and Testing Market Share by Region: 2022 VS 2033
Figure 15. Global Cancer Therapy and Testing Market Share by Players in 2022
Figure 16. Global Top Cancer Therapy and Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Therapy and Testing as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Cancer Therapy and Testing Revenue in 2022
Figure 18. North America Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Cancer Therapy and Testing Market Share by Type (2018-2033)
Figure 20. North America Cancer Therapy and Testing Market Share by Application (2018-2033)
Figure 21. North America Cancer Therapy and Testing Market Share by Country (2018-2033)
Figure 22. United States Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Cancer Therapy and Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 25. Europe Cancer Therapy and Testing Market Share by Type (2018-2033)
Figure 26. Europe Cancer Therapy and Testing Market Share by Application (2018-2033)
Figure 27. Europe Cancer Therapy and Testing Market Share by Country (2018-2033)
Figure 28. Germany Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. China Cancer Therapy and Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 35. China Cancer Therapy and Testing Market Share by Type (2018-2033)
Figure 36. China Cancer Therapy and Testing Market Share by Application (2018-2033)
Figure 37. Asia Cancer Therapy and Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 38. Asia Cancer Therapy and Testing Market Share by Type (2018-2033)
Figure 39. Asia Cancer Therapy and Testing Market Share by Application (2018-2033)
Figure 40. Asia Cancer Therapy and Testing Market Share by Region (2018-2033)
Figure 41. Japan Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. China Taiwan Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Cancer Therapy and Testing Market Size YoY (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Cancer Therapy and Testing Market Share by Type (2018-2033)
Figure 49. Middle East, Africa, and Latin America Cancer Therapy and Testing Market Share by Application (2018-2033)
Figure 50. Middle East, Africa, and Latin America Cancer Therapy and Testing Market Share by Country (2018-2033)
Figure 51. Brazil Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Mexico Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Turkey Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Israel Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. GCC Countries Cancer Therapy and Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Invitae Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 58. Foundation Medicine Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 59. Guardant Health Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 60. Illumina Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 61. Sysmex Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 62. Abingdon Health Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 63. Sophia Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 64. NanoEntek Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 65. BGI Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 66. Diagnosis Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 67. Exact Sciences Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 68. AstraZeneca Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 69. Bayer AG Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 70. Johnson & Johnson Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 71. Pfizer Inc. Revenue Growth Rate in Cancer Therapy and Testing Business (2018-2023)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed